This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by An, H.-X. Articles by Schwab, M. Search for Related Content PubMed PubMed Citation Articles by An, H.-X. Articles by Schwab, M.

Two Regions of Deletion in 9p23–24 in Sporadic Breast Cancer¹

Division of Cytogenetics, German Cancer Research Center, D-69120 Heidelberg [H-X. A., A. C., L. S., M. S.], Division for Surgery and Surgical Oncology, Robert-Rössle-Klinik [P. S.], and Department of Tumor Genetics, Max Delbrück Center for Molecular Medicine-Berlin, D-13122 Berlin [S. Se., S. Sc.], Germany

Allelic deletions of 9p including band 21–22 are common in various types of human carcinomas including breast cancer. Our previous cytogenetic studies had identified constitutional chromosomal changes in 9p23–24 in patients of a male-breast-cancer family and 9p23–24 alterations in a cell line established from a sporadic female breast cancer. To find out whether this genomic region is involved more frequently in alterations in sporadic breast cancers, we have surveyed 80 microdissected tumor samples for both loss of heterozygosity (LOH) and homozygous deletion at 22 microsatellite loci spanning 9p22 to 9p24 using fluorescent multiplex PCR. LOH at one or more loci was observed in 32 (40%) of these tumors. Homozygous deletion was detected in four cases. Eleven tumors had LOH at all of the informative loci analyzed, whereas 21 tumors showed partial-terminal or interstitial allelic loss of 9p. Deletion mapping identified two common regions of deletion: (a) 4 cM including D9S281 to D9S286; and (b) 1 cM including D9S1808 to D9S268.

This article has been cited by other articles:

				H. Su, J.-R. Yang, T. Xu, J. Huang, L. Xu, Y. Yuan, and S.-M. Zhuang MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity Cancer Res., February 1, 2009; 69(3): 1135 - 1142. [Abstract] [Full Text] [PDF]

				H. Wang, D. Teske, A. Tess, R. Kohlhepp, Y. Choi, C. Kendziorski, and A. R. Moser Identification of Novel Modifier Loci of ApcMin Affecting Mammary Tumor Development Cancer Res., December 1, 2007; 67(23): 11226 - 11233. [Abstract] [Full Text] [PDF]

				B. S. Schaffer, C. M. Lachel, K. L. Pennington, C. R. Murrin, T. E. Strecker, M. Tochacek, K. A. Gould, J. L. Meza, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway x ACI Intercross. Cancer Res., August 1, 2006; 66(15): 7793 - 7800. [Abstract] [Full Text] [PDF]

				K. A. Gould, M. Tochacek, B. S. Schaffer, T. M. Reindl, C. R. Murrin, C. M. Lachel, E. A. VanderWoude, K. L. Pennington, L. A. Flood, K. K. Bynote, et al. Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat: Mapping of Emca1 and Emca2 to Chromosomes 5 and 18 Genetics, December 1, 2004; 168(4): 2113 - 2125. [Abstract] [Full Text] [PDF]

				I. Wittke, R. Wiedemeyer, A. Pillmann, L. Savelyeva, F. Westermann, and M. Schwab Neuroblastoma-Derived Sulfhydryl Oxidase, a New Member of the Sulfhydryl Oxidase/Quiescin6 Family, Regulates Sensitization to Interferon {gamma}-Induced Cell Death in Human Neuroblastoma Cells Cancer Res., November 15, 2003; 63(22): 7742 - 7752. [Abstract] [Full Text] [PDF]

				P. M. Pollock, J. Welch, and N. K. Hayward Evidence for Three Tumor Suppressor Loci on Chromosome 9p Involved in Melanoma Development Cancer Res., February 1, 2001; 61(3): 1154 - 1161. [Abstract] [Full Text]

				A. Castells, J. F. Gusella, V. Ramesh, and A. K. Rustgi A Region of Deletion on Chromosome 22q13 Is Common to Human Breast and Colorectal Cancers Cancer Res., June 1, 2000; 60(11): 2836 - 2839. [Abstract] [Full Text] [PDF]